SwissMedic-2021-0029-V329
Type II variation for application SwissMedic-2021-0029. Type II variation: Container Closure Change for Atezolimumab-R — routine update
Variation Number
SwissMedic-2021-0029-V329
Type
Type II
Application
Change
Status
Overdue
Fee
€8,846
Submitted
—
Approved
—
Description
Type II variation: Container Closure Change for Atezolimumab-R — routine update